A single nucleotide polymorphism at chromosome 2q21.3 (LCT-13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation

3Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A single nucleotide polymorphism (SNP) responsible for lactase persistence (LCT-13910C>T) changes intestinal microflora. Considering the influence of bacterial microflora on various immune effects, we tested DNA from 111 recipients/donors and analyzed whether this SNP interferes with survival and the incidence of acute graft-versushost disease (aGVHD) after allogeneic hematopoetic stem cell tranplantations (HSCT). Median overall survival (OS) was significantly longer when donors had a CC genotype (not reached after 133 vs 11.1 months, P=.004). Multivariate analysis identified a donor T allele (hazard ratio 2.63, 95% confidence interval 1.29-5.33, P=.008) as independent risk factor for death. Surprisingly, recipient genotypes did not influence outcome and there were no differences regarding aGVHD. Transplantation-related mortality (TRM), relapse and pneumonia were significantly less frequent in patients with CC donors. These findings add to the growing list of non-HLA polymorphisms with impact on outcome after allogeneic HSCT. © 2008 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Hauser, H., Zach, O., Krieger, O., Kasparu, H., Koenig, J., Girschikofsky, M., … Lutz, D. (2008). A single nucleotide polymorphism at chromosome 2q21.3 (LCT-13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation. Blood, 112(5), 2156–2159. https://doi.org/10.1182/blood-2008-02-139766

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free